Quantitative changes in CD8+CD57+ population were observed, among others, in multiple sclerosis [23], type 1 diabetes [23], Graves' disease [24], and rheumatoid arthritis [25]. This evidence concerns the gene B3GAT1 and type 1 diabetes mellitus.